Frenova’s Clinical Trial Site Management Services Make It a Lot Easier

Clinical trial investigators are essential to the development of medicines to fight kidney disease and its comorbid conditions. As the leading global manager of nephrology-oriented sites, Frenova gives investigators the help they need to successfully integrate and manage research within their nephrology practices.

Because of our 20+ years of nephrology experience and unparalleled insight into renal disease and patient care, we are the trusted patient-centric authority for helping sponsors develop practical study protocols for nephrology clinical trials. Our mindful protocol designs ease study execution, boost operational efficiency and improve patient adherence, making investigators’ jobs easier.

In addition, we prime our investigator network for rapid site startup and help streamline clinical trial recruitment and enrollment. With Frenova’s management, you will be able to deliver the reliable performance and high-quality data sponsors need to gain critical insights and advance the science of renal therapies. And you’ll still have time for your patients.

Why join Frenova’s network of managed clinical trial sites?

Discoveries Require the Work of Clinical Investigators

Investigators play an important role in contributing to the discovery of new medicines that could change the lives of their patients and influence health care worldwide. Today, more physicians are acutely needed to help evaluate new products for potentially lifesaving therapeutics. Greater physician involvement will help accelerate development and contain the cost of developing new drugs.

Patients Are Interested in Trying New Alternatives

Patients see value in the opportunity to obtain clinical care and possibly access new medicines that they might not normally be able to afford. In addition, research indicates that many patients feel good about participating in studies to help others.

How Do I Add Research to My Practice and Still Have Time for Patients? FRENOVA KNOWS.

Find Out More

Clinical Trials Offer a New Revenue Stream

Clinical trials offer the opportunity for additional revenue that can help you expand your clinical practice. Frenova site management will help you make the most of this aspect of including research in your clinical nephrology practice.

Clinical Research Enhances Your Professional Profile

Conducting clinical trials allows you to be at the forefront of renal research. You will have opportunities to connect with other investigators, exchange ideas and learn about best practices.

Frenova Empowers Investigators and Research Teams to Maximize Site Performance and Success

Frenova Renal Research partners with our principal investigators to improve their operations and help them conduct clinical research efficiently. We help you implement best practices, ensure compliance, build the right infrastructure, define job roles and conduct training on regulations, research and financial management.

Related Resources

White Paper

Building a Global Research Network: Chronic Kidney Disease as a Public Health Crisis

At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However,...

Video

Start with the Patient in Mind® – Interview With Patient Partner Donnie King

Start with the patient in mind — let’s renew our resolve to represent those who participate in studies to advance...

Case Study

Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught

Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant...

White Paper

Protocol Design Trends Investigators Should Look for When Selecting Studies

For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote...

Brochure

Access to Patients = Exceeded Enrollment

See how Frenova’s clinical research sites, through rapid startup, leveraged relationships and site management achieved enrollment goals in less time...